Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile Neutropenia
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations
- Status
- UNKNOWN
- Phase
- PHASE2
Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
- Status
- RECRUITING
- Phase
- PHASE2
Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE2
Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
- Status
- COMPLETED
- Phase
- N/A
A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Methods of T Cell Depletion Trial (MoTD)
- Status
- RECRUITING
- Phase
- PHASE2
Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML
- Status
- TERMINATED
- Phase
- PHASE1
Feasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- NA
Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
- Status
- RECRUITING
- Phase
- PHASE1
Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy
- Status
- TERMINATED
- Phase
- N/A
Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML
- Status
- COMPLETED
- Phase
- PHASE3
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
BST-236 as a Single Agent in Adults With Relapsed or Refractory AML or HR-MDS
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)
- Status
- COMPLETED
- Phase
- PHASE1
A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2